Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.915 USD | +9.97% | +6.98% | +613.22% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+613.22% | 195M | |
+6.99% | 111B | |
+10.81% | 106B | |
-13.02% | 22.24B | |
+0.12% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-10.00% | 16.81B | |
+38.87% | 12.54B | |
-24.60% | 8.09B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Wedbush Raises Elevation Oncology's PT to $8 From $5, Continues to See 'Intriguing' Opportunity in Shares; Keeps Outperform Rating